Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)

This study has been terminated.
(Lack of funding)
Information provided by:
Nova Scotia Health Authority Identifier:
First received: May 30, 2008
Last updated: June 23, 2011
Last verified: February 2009
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2009
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)